Articles published by La Jolla Pharmaceutical Company
![](https://mms.businesswire.com/media/20221014005417/en/308318/4/LaJollaLogo-300px_1-20-12.jpg)
![](https://mms.businesswire.com/media/20220711005314/en/1509126/4/Innoviva_Logo.jpg)
Innoviva to Acquire La Jolla Pharmaceutical Company
July 11, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220516005125/en/1455335/5/LJPC_logo.jpg)
![](https://mms.businesswire.com/media/20211117005448/en/928132/5/LJPC_logo.jpg)
La Jolla Pharmaceutical Company Announces Share Repurchase Plan
November 17, 2021
Via Business Wire
Tickers
LJPC
![](https://mms.businesswire.com/media/20211104005327/en/923561/5/LJPC_logo.jpg)
![](https://mms.businesswire.com/media/20210910005119/en/904849/5/LJPC_logo.jpg)
Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company
September 10, 2021
Via Business Wire
Tickers
LJPC
![](https://mms.businesswire.com/media/20210805005263/en/896664/5/LJPC_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.